e-learning
resources
Munich 2014
Monday, 08.09.2014
COPD exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of chronic kidney disease (CKD) in the UK COPD population
D. Price, E. Davis, A. Gilchrist, D. West, M. Kerklof, D. Ryan (Cambridge, Aberdeen, United Kingdom)
Source:
International Congress 2014 – COPD exacerbations
Session:
COPD exacerbations
Session type:
Oral Presentation
Number:
1939
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Price, E. Davis, A. Gilchrist, D. West, M. Kerklof, D. Ryan (Cambridge, Aberdeen, United Kingdom). Prevalence of chronic kidney disease (CKD) in the UK COPD population. Eur Respir J 2014; 44: Suppl. 58, 1939
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014
Characteristics of essential hypertension in COPD patients
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Comorbidity in patients with COPD in Russia
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Obesity and impairments in chronic obstruction pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Nutritional status in chronic obstructive pulmonary disease
Source: International Congress 2014 – Comorbidities
Year: 2014
Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Secondary prevention of osteoporosis (OP) in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015
Investigation of sarcopenia in Japanese COPD patients
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
Dietary habits in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013
Diabetes and hospitalization for COPD exacerbation
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Prevalence of COPD in vascular diseases
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
Peripheral neuropathy in chronic obstructive pulmonary disease
Source: International Congress 2014 – Comorbidities
Year: 2014
Clinical features of chronic obstructive pulmonary disease in never smokers
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Chronic obstructive pulmonary disease assessment test (CAT) in patients with COPD, chronic heart failure (CHF), and both
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
LATE-BREAKING ABSTRACT: Risk factors for hospitalization and death in elderly smokers with chronic obstructive pulmonary disease (COPD) and/or chronic heart failure (CHF)
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016
LATE-BREAKING ABSTRACT: Multidimensional assessment of patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Predictors
Year: 2014
Prescription of opioids for breathlessness in end-stage chronic obstructive pulmonary disease: A national population based study
Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Year: 2016
Prevalence of chronic obstructive pulmonary disease (COPD) in a general population in Norway
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept